Amirhossein Ghaseminejad-Raeini
Overview
Explore the profile of Amirhossein Ghaseminejad-Raeini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darijani S, Seyedmirzaei H, Nakhostin-Ansari A, Menbari-Oskouie I, Ghaseminejad-Raeini A, Nasoori H, et al.
Balkan Med J
. 2025 Mar;
42(2):138-149.
PMID: 40033654
Background: Studies on the burden and epidemiological aspects of substance-use disorders in the Middle East and North Africa (MENA) are limited. Aims: To evaluate the burden and epidemiology of substance-use...
2.
Shirinezhad A, Eshlaghi F, Salabat D, Azarboo A, Ardakani Z, Esmaeili S, et al.
BMC Gastroenterol
. 2025 Feb;
25(1):115.
PMID: 40000980
Background: Hepatic liver cirrhosis can lead to significant systemic complications, including the deterioration of bone health. The resulting bone complications can contribute to a decreased quality of life and increased...
3.
Hoveidaei A, Pirahesh K, Kanaani Nejad F, Ghaseminejad-Raeini A, Nwankwo B, Conway J
J Orthop Trauma
. 2025 Feb;
PMID: 39976926
Objectives: To evaluate whether people experiencing homelessness (PEH) have more postoperative complications following hemiarthroplasty, total hip arthroplasty (THA), hip open reduction and internal fixation (ORIF), and percutaneous skeletal fixation surgeries...
4.
Mirghaderi P, Mortezaei A, Javidan A, Ghaseminejad-Raeini A, Nematollahi B
Clin Rheumatol
. 2025 Feb;
PMID: 39976796
Objective: This systematic review aims to evaluate the efficacy and safety of various biological products, such as platelet-rich plasma (PRP), hyaluronic acid (HA), and combination treatments, in alleviating pain and...
5.
Azarboo A, Daneshvar M, Abroy A, Assempoor R, Taghvaei A, Nasrollahizadeh A, et al.
Egypt Heart J
. 2025 Jan;
77(1):13.
PMID: 39841407
Background: Many studies have validated the use of antiplatelet or anticoagulant therapy in coronary artery ectasia (CAE) to reduce major adverse cardiovascular events (MACE); however, it is not completely known...
6.
Shirinezhad A, Azarboo A, Ghaseminejad-Raeini A, Kanaani Nejad F, Zareshahi N, Amiri S, et al.
Front Endocrinol (Lausanne)
. 2025 Jan;
15:1499479.
PMID: 39744182
Background: The relationship of insulin resistance with bone mineral density (BMD) remains unclear, offering an opportunity for novel indices to shed light on the matter. The aim of this review...
7.
Shirinezhad A, Azarboo A, Mafhoumi A, Islampanah M, Mohammadi S, Ghaseminejad-Raeini A, et al.
J Diabetes Metab Disord
. 2024 Dec;
24(1):6.
PMID: 39697860
Background: Urinary pentosidine, an advanced glycation end product (AGE), has been proposed as a potential biomarker for impaired bone health, especially in older adults and those with diabetes. This study...
8.
Hoveidaei A, Ghaseminejad-Raeini A, Jebeli-Fard R, Hosseini-Asl S, Luo T, Sandiford N, et al.
Arch Orthop Trauma Surg
. 2024 Dec;
145(1):53.
PMID: 39680211
Purpose: The aim of this study was to perform a systematic review of the current literature to elucidate the optimal duration of systemic antibiotic therapy following one-stage revision TKA in...
9.
Esmaeili S, Shaker F, Ghaseminejad-Raeini A, Baghchi M, Sajadi S, Shafiei S
BMC Musculoskelet Disord
. 2024 Nov;
25(1):976.
PMID: 39609839
Introduction: Acetabular fractures can lead to persistent pain and disability. Managing these complex injuries involves several treatment options such as nonoperative methods, percutaneous fixation, open reduction internal fixation (ORIF), and...
10.
Hoveidaei A, Shahul S, Esmaeili S, Pirahesh K, Ghaseminejad-Raeini A, Annasamudram A, et al.
Antibiotics (Basel)
. 2024 Nov;
13(11).
PMID: 39596762
Background: Osteomyelitis is a challenging condition caused by infection and inflammation of the bone, presenting a significant economic burden to healthcare systems. Calcium sulfate/hydroxyapatite (CaS/HA) is a bone void filler...